PT Medikaloka Hermina Tbk (HEAL.JK)
IDR 1420.0
(-1.73%)
IDR 1420.0
(-1.73%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1584.42 Billion IDR | 103.3% |
| 2022 | 1174.25 Billion IDR | -60.7% |
| 2021 | 2224.95 Billion IDR | 66.96% |
| 2020 | 1369.73 Billion IDR | 63.82% |
| 2019 | 810.87 Billion IDR | 29.83% |
| 2018 | 593.69 Billion IDR | 4.61% |
| 2017 | 551.72 Billion IDR | 17.8% |
| 2016 | 463.88 Billion IDR | 46.03% |
| 2015 | 314.58 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 326.43 Billion IDR | -4.94% |
| 2024 Q2 | 483.15 Billion IDR | -0.97% |
| 2024 Q1 | 483.13 Billion IDR | 18.81% |
| 2023 Q3 | 342.38 Billion IDR | 37.73% |
| 2023 Q2 | 248.59 Billion IDR | 2.08% |
| 2023 Q1 | 243.52 Billion IDR | 60.85% |
| 2023 FY | - IDR | 103.3% |
| 2023 Q4 | 392.94 Billion IDR | 14.77% |
| 2022 Q1 | 271.91 Billion IDR | -32.03% |
| 2022 FY | - IDR | -60.7% |
| 2022 Q4 | 151.39 Billion IDR | -17.58% |
| 2022 Q3 | 183.69 Billion IDR | 32.83% |
| 2022 Q2 | 138.29 Billion IDR | -49.14% |
| 2021 Q3 | 430.91 Billion IDR | -16.74% |
| 2021 Q1 | 547.69 Billion IDR | 8.66% |
| 2021 Q2 | 517.56 Billion IDR | -5.5% |
| 2021 FY | - IDR | 66.96% |
| 2021 Q4 | 400.06 Billion IDR | -7.16% |
| 2020 Q4 | 504.03 Billion IDR | 55.88% |
| 2020 Q2 | 110.37 Billion IDR | -44.26% |
| 2020 Q3 | 323.34 Billion IDR | 192.96% |
| 2020 Q1 | 198.01 Billion IDR | 36.53% |
| 2020 FY | - IDR | 63.82% |
| 2019 Q3 | 201.28 Billion IDR | 15.63% |
| 2019 Q1 | 172.93 Billion IDR | 31.97% |
| 2019 FY | - IDR | 29.83% |
| 2019 Q4 | 145.03 Billion IDR | -27.95% |
| 2019 Q2 | 174.07 Billion IDR | 0.66% |
| 2018 Q1 | 135.65 Billion IDR | 2.48% |
| 2018 FY | - IDR | 4.61% |
| 2018 Q4 | 131.04 Billion IDR | -0.11% |
| 2018 Q3 | 131.18 Billion IDR | -3.63% |
| 2018 Q2 | 136.13 Billion IDR | 0.35% |
| 2017 Q2 | 180.67 Billion IDR | 0.0% |
| 2017 Q1 | 180.67 Billion IDR | 0.0% |
| 2017 Q3 | 146.4 Billion IDR | -18.97% |
| 2017 Q4 | 132.36 Billion IDR | -9.58% |
| 2017 FY | - IDR | 17.8% |
| 2016 FY | - IDR | 46.03% |
| 2015 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Bundamedik Tbk | 223.9 Billion IDR | -607.623% |
| PT Metro Healthcare Indonesia Tbk | -7.68 Billion IDR | 20729.947% |
| PT Mitra Keluarga Karyasehat Tbk | 1555.38 Billion IDR | -1.867% |
| PT Murni Sadar Tbk | 155.6 Billion IDR | -918.22% |
| PT Famon Awal Bros Sedaya Tbk | 443.01 Billion IDR | -257.649% |
| PT Royal Prima Tbk | 52.4 Billion IDR | -2923.252% |
| PT Kedoya Adyaraya Tbk | 61.12 Billion IDR | -2492.236% |
| PT Sarana Meditama Metropolitan Tbk | 323.18 Billion IDR | -390.252% |
| PT Siloam International Hospitals Tbk | 2692.46 Billion IDR | 41.153% |
| PT Sejahteraraya Anugrahjaya Tbk | 437.22 Billion IDR | -262.379% |